Related Experiment Video
Updated: Jun 10, 2026
08:54
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Aurora kinase A in Barrett's carcinogenesis
Massimo Rugge1, Matteo Fassan, Giovanni Zaninotto
1Department of Medical Diagnostic Sciences & Special Therapies, Pathology Unit, University of Padova, Padua, Italy. massimo.rugge@unipd.it
Human Pathology
|July 27, 2010
Summary
Overexpression of the AURKA gene is linked to esophageal cancer progression in Barrett's mucosa. This finding suggests AURKA as a potential therapeutic target for preventing Barrett's adenocarcinoma development.
Area of Science:
- Gastroenterology
- Oncology
- Molecular Biology
Background:
- Barrett's mucosa is a precursor to esophageal adenocarcinoma.
- Aneuploidy and TP53 mutations are established risk markers for Barrett's adenocarcinoma.
- The role of mitotic kinase gene AURKA in this progression is under investigation.
Purpose of the Study:
- To investigate the association between AURKA expression, chromosome instability, and histological progression in Barrett's mucosa.
- To evaluate AURKA as a potential biomarker and therapeutic target in Barrett's carcinogenesis.
Main Methods:
- Immunohistochemical analysis of AURKA and TP53 expression in 87 Barrett's mucosa biopsy samples and 25 controls.
- Calculation of the micronuclei index to assess chromosome instability.
- Correlation analysis between AURKA expression, p53 expression, and micronuclei index.
Main Results:
- AURKA immunostaining significantly increased with dedifferentiation of histological phenotype (P < .001).
- Nine out of 10 Barrett's adenocarcinomas showed AURKA immunostaining.
- AURKA expression strongly correlated with p53 expression and the micronuclei index (both Ps < .001).
Conclusions:
- AURKA overexpression is significantly associated with the progression of Barrett's mucosa to adenocarcinoma.
- AURKA contributes to esophageal carcinogenesis by promoting chromosome instability.
- AURKA represents a novel molecular target for therapeutic strategies in Barrett's mucosa patients.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:21Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...